MedTrace Logo

Exploring the Effects of Sonic Augmentation Technology in Music

NCT06902506 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-02-12

No results posted yet for this study

Summary

Brief Summary:

It is the specific intent of this proposal to experimentally explore the possible benefits and mechanisms through which Sonic Augmentation Technology in music can influence emotional health, embodiment, and autonomic functioning. The main goals of the study are:

* To examine the immediate effects of listening to the music.
* To identify individual characteristics that influence the effectiveness of listening to the music.
* Phase 1 ONLY: To examine whether the participants who received the augmented theme reported more improvements than the participants who received the non-augmented theme.

Participants will be asked to attend a scheduled online Zoom meeting where they will:

* Listen to 15-minutes of music
* Complete a pre-music and post-music online survey
* Phase 1 ONLY: Attend the lecture/discussion with Dr. Porges and Anthony Gorry on theory and science underlying sonic augmentation technology and the experiences it aims to evoke.

Conditions

  • Sonic Augmentation Technology

Interventions

BEHAVIORAL

Augmented Music

Phase 1 \& 2: The music is augmented by embedding the natural rhythms of bodily functions (e.g. breathing, heart rate variability, vascular tone, etc) that signal the body to calm.

BEHAVIORAL

Non-augmented Music

Phase 1 ONLY: Same melodic theme without the augmentation.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Lourdes P Dale, BS · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-05
Primary Completion
2026-08-29
Completion
2026-08-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06902506 on ClinicalTrials.gov